J. Biol. Chem., Vol. 259, Issue 10, 6052-6055, May, 1984

Site of insulin inhibition of cAMP-stimulated glycogenolysis

RA Gabbay and HA Lardy

Insulin antagonized the glycogenolytic actions of cAMP in isolated hepatocytes even in the presence of the phosphodiesterase inhibitors, 1- methyl-3-isobutylxanthine or d-4-(3-butoxy-4-methoxybenzyl)-2- imidizolidione . Stimulation of glucose release by 8-bromo-cAMP, which is not appreciably hydrolyzed by phosphodiesterase, was also inhibited by insulin in the presence of d-4-(3-butoxy-4-methoxybenzyl)-2- imidizolidione . This demonstrates that insulin can antagonize cAMP stimulation of glycogenolysis independent of possible effects of insulin on adenylate cyclase or phosphodiesterase. Under conditions where changes in cyclic adenine nucleotide concentrations (cAMP and 8- bromo-cAMP) were prevented, insulin depressed the 8-bromo-cAMP- stimulated protein kinase activity ratio. We conclude that phosphodiesterase activation is not required for insulin antagonism of cAMP-stimulated glycogenolysis. The effect of insulin under these conditions can be explained by an action of insulin on cAMP-dependent protein kinase independent of changes in cAMP levels.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. V. Rao, S. Pugazhenthi, and R. L. Khandelwal The Effects of Streptozotocin-induced Diabetes and Insulin Supplementation on Expression of the Glycogen Phosphorylase Gene in Rat Liver J. Biol. Chem., October 20, 1995; 270(42): 24955 - 24960. [Abstract] [Full Text] [PDF]

				R. Unger Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells Science, March 8, 1991; 251(4998): 1200 - 1205. [Abstract] [PDF]